Literature DB >> 8648718

Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

D J Volsky1, M Simm, M Shahabuddin, G Li, W Chao, M J Potash.   

Abstract

It is thought that interference during human immunodeficiency virus type 1 (HIV-1) infection is established by downmodulation of the principal virus receptor, CD4. Here we present evidence to the contrary. At various times after primary infection, we superinfected T cells in vitro by exposure to a genetically distinct viral clone or to a virus carrying the chloramphenicol acetyltransferase gene. Replication of each virus strain was determined by restriction enzyme analysis of total cellular DNA, by PCR amplification of viral DNA, or by assay of cell extracts for chloramphenicol acetyltransferase activity. We found that efficient viral interference is established within 24 h of infection at a multiplicity of infection of 1. At that time, expression of viral structural proteins was low and infected cells displayed undiminished levels of surface CD4 and were fully susceptible to virus binding and fusion. Superinfection by either cell-free HIV-1 or cocultivation was blocked. Cells resistant to superinfection by HIV-1 remained susceptible to Moloney murine leukemia and vaccinia viruses. No interference was observed 4 h after primary infection or in cells infected with either UV-inactivated HIV-1 or a mutant virus defective in virus-cell fusion activity, indicating that binding of primary virus to CD4 is insufficient to prevent superinfection. The minimum viral requirements for this interference are that HIV-1 must be able to enter cells and synthesize viral DNA; Tat-mediated transcription is dispensable. Our results support the existence of a novel pathway to interference to HIV-1 infection, which we term postentry interference, which blocks superinfection during intracellular phases of the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648718      PMCID: PMC190259     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.

Authors:  B Crise; L Buonocore; J K Rose
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

Review 2.  Retroviral reverse transcriptase: synthesis, structure, and function.

Authors:  S P Goff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector.

Authors:  A Caputo; J G Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection.

Authors:  M Somasundaran; H L Robinson
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

5.  Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events.

Authors:  H L Robinson; D M Zinkus
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses.

Authors:  D Ott; R Friedrich; A Rein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.

Authors:  E F Terwilliger; B Godin; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.

Authors:  H E Gendelman; L M Baca; J Turpin; D C Kalter; B Hansen; J M Orenstein; C W Dieffenbach; R M Friedman; M S Meltzer
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

9.  Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates.

Authors:  E I Golub; G G Li; D J Volsky
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

10.  Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.

Authors:  C D Pauza; J E Galindo; D D Richman
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  13 in total

1.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

2.  gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.

Authors:  P D'Aloja; E Olivetta; R Bona; F Nappi; D Pedacchia; K Pugliese; G Ferrari; P Verani; M Federico
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.

Authors:  Lingbing Zeng; Vicente Planelles; Ziye Sui; Suzanne Gartner; Sanjay B Maggirwar; Stephen Dewhurst; Linbai Ye; Vivek R Nerurkar; Richard Yanagihara; Yuanan Lu
Journal:  J Gene Med       Date:  2006-01       Impact factor: 4.565

4.  Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.

Authors:  B R Gundlach; S Reiprich; S Sopper; R E Means; U Dittmer; K Mätz-Rensing; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.

Authors:  Zachary Klase; Kuan-Teh Jeang
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

6.  Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells.

Authors:  A A Bukovsky; J P Song; L Naldini
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.

Authors:  M G Lewis; J Yalley-Ogunro; J J Greenhouse; T P Brennan; J B Jiang; T C VanCott; Y Lu; G A Eddy; D L Birx
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.

Authors:  M Pistello; D Matteucci; G Cammarota; P Mazzetti; S Giannecchini; D Del Mauro; S Macchi; L Zaccaro; M Bendinelli
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.

Authors:  Beihui Liu; Shu Wang; Michael Brenner; Julian F R Paton; Sergey Kasparov
Journal:  J Gene Med       Date:  2008-05       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.